Polaris Group

TW:6550 Taiwan Biotechnology
Market Cap
$619.85 Million
NT$20.51 Billion TWD
Market Cap Rank
#13650 Global
#445 in Taiwan
Share Price
NT$23.85
Change (1 day)
+9.91%
52-Week Range
NT$21.70 - NT$44.25
All Time High
NT$218.00
About

Polaris Group, together with its subsidiaries, offers biotechnology, drug testing, and contract development and manufacturing services. The company engages in the research, development, manufacture and sale of new drugs. It develops ADI-PEG 20 for the treatment of various cancer indications, as well as provides healthcare consulting, staffing, and MDS solutions. The company was incorporated in 20… Read more

Polaris Group (6550) - Total Assets

Latest total assets as of September 2025: NT$8.18 Billion TWD

Based on the latest financial reports, Polaris Group (6550) holds total assets worth NT$8.18 Billion TWD as of September 2025.

Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Polaris Group - Total Assets Trend (2016–2024)

This chart illustrates how Polaris Group’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.

Polaris Group - Asset Composition Analysis

Current Asset Composition (December 2024)

Polaris Group's total assets of NT$8.18 Billion consist of 36.6% current assets and 63.4% non-current assets.

Asset Category Amount (TWD) % of Total Assets
Cash & Equivalents NT$0.00 21.4%
Accounts Receivable NT$24.49 Million 0.3%
Inventory NT$67.38 Million 0.7%
Property, Plant & Equipment NT$0.00 0.0%
Intangible Assets NT$1.43 Billion 15.7%
Goodwill NT$755.42 Million 8.3%

Asset Composition Trend (2016–2024)

This chart illustrates how Polaris Group's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Polaris Group's current assets represent 36.6% of total assets in 2024, an increase from 19.0% in 2016.
  • Cash Position: Cash and equivalents constituted 21.4% of total assets in 2024, up from 18.2% in 2016.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 23.0% of total assets, an increase from 0.0% in 2016.
  • Asset Diversification: The largest asset category is intangible assets at 15.7% of total assets.

Polaris Group Competitors by Total Assets

Key competitors of Polaris Group based on total assets are shown below.

Company Country Total Assets
MedPacto Inc
KQ:235980
Korea ₩51.58 Billion
2H0
F:2H0
Germany €15.27 Million
Shenzhen CAU Technology Co Ltd
SHE:000004
China CN¥260.55 Million
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
China CN¥9.58 Billion
Nanhua Bio Medicine Co Ltd
SHE:000504
China CN¥841.96 Million
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
China CN¥509.14 Million
Chengzhi Shareholding Co Ltd
SHE:000990
China CN¥27.52 Billion
Hualan Biological EngineeringInc
SHE:002007
China CN¥16.27 Billion

Polaris Group - Asset Efficiency Metrics

Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.

Asset Turnover Ratio

Measures how efficiently a company uses its assets to generate sales

Historical Range: 0.00 - 0.01

Lower asset utilization - Polaris Group generates 0.01x its asset value in annual revenue.

Return on Assets (ROA)

Measures how efficiently a company uses its assets to generate profits

Historical Range: -27.53% - -9.47%

Negative ROA - Polaris Group is currently not profitable relative to its asset base.

Polaris Group - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.30 6.67 12.72
Quick Ratio 1.24 6.52 12.72
Cash Ratio 0.00 0.00 0.00
Working Capital NT$538.82 Million NT$ 2.40 Billion NT$ 5.89 Billion

Polaris Group - Advanced Valuation Insights

This section examines the relationship between Polaris Group's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 6.24
Latest Market Cap to Assets Ratio 0.03
Asset Growth Rate (YoY) -0.1%
Total Assets NT$9.09 Billion
Market Capitalization $258.65 Million USD

Valuation Analysis

Below Book Valuation: The market values Polaris Group's assets below their book value (0.03 x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Polaris Group's assets decreased by 0.1% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Polaris Group (2016–2024)

The table below shows the annual total assets of Polaris Group from 2016 to 2024.

Year Total Assets Change
2024-12-31 NT$9.09 Billion -0.08%
2023-12-31 NT$9.10 Billion -1.32%
2022-12-31 NT$9.22 Billion +17.86%
2021-12-31 NT$7.82 Billion +132.64%
2020-12-31 NT$3.36 Billion -18.11%
2019-12-31 NT$4.11 Billion +107.83%
2018-12-31 NT$1.98 Billion -11.08%
2017-12-31 NT$2.22 Billion +12.77%
2016-12-31 NT$1.97 Billion --